Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease

Formiga F, Moreno-Gónzalez R, Corsonello A, Mattace-Raso F, Carlsson AC, Ärnlöv J, Kostka J, Freiberger E, Roller-Wirnsberger R, Tap L, Sołtysik BK, Artzi-Medvedik R, Kob R, Yehoshua I, Wirnsberger GH, Fabbietti P, Lattanzio F, Chivite D (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Gerontology

Book Volume: 70

Pages Range: 507-516

Journal Issue: 5

DOI: 10.1159/000536465

Abstract

INTRODUCTION: Sarcopenia, heart failure (HF), and chronic kidney disease (CKD) are common among the older people. Our objective was to evaluate the frequency of sarcopenia, among community-dwelling older adults with HF, possible causative factors, and the additive factor of CKD. METHODS: A cross-sectional analysis of 1,420 older people living in the community was carried out. Participants (aged 75 years and more) came from a European multicenter prospective cohort (SCOPE study). Global geriatric assessment including short physical performance battery, handgrip strength test, and bioelectrical impedance analysis was performed. Previous known HF was defined as physician-diagnosed HF registered in the patient's medical record or the use of HF-related medications, regardless of left ventricular ejection fraction (LVEF). Sarcopenia was defined by the updated criteria of the European Working Group on Sarcopenia in Older People (EWGSOP2). Estimated glomerular filtration rate was calculated using Berlin Initiative Study (BIS) to define the stages of CKD. Two-year mortality was also collected. RESULTS: A total of 226 (15.9%) participants had a prior chronic HF diagnosis, with a median age of 80.0 (5.0), and 123 (54.4%) were women. Using EWGSOP2 definition, 11.5% HF and 10.7% in non-HF participants met diagnostic criteria for sarcopenia. In multivariate analyses, only a lower body mass index (BMI) (odds ratios [OR], 0.82; 95% confidence interval [CI], 0.73-0.93) and lower short physical performance battery score (OR, 0.81; 95% CI, 0.69-0.96) were associated with sarcopenia. Patients with HF and sarcopenia have a similar all-cause mortality risk but higher 2-year cardiovascular mortality risk (p = 0.047). DISCUSSION/CONCLUSION: One out of ten community-dwelling older adults with concurrent clinical stable chronic HF, without considering LVEF, have sarcopenia. Lower BMI and poor physical performance are associated with sarcopenia in this population, but not CKD.

Authors with CRIS profile

Ellen Freiberger Lehrstuhl für Innere Medizin (Geriatrie) Robert Kob Lehrstuhl für Innere Medizin (Geriatrie)

Involved external institutions

Ben-Gurion University of the Negev (BGU) / אוניברסיטת בן-גוריון בנגב IL Israel (IL) Bellvitge University Hospital / Hospital Universitari de Bellvitge ES Spain (ES) Istituto Nazionale di Riposo e Cura per Anziani (IRCCS INRCA) IT Italy (IT) Erasmus University Medical Center (MC) NL Netherlands (NL) Karolinska Institute SE Sweden (SE) Medizinische Universität Graz AT Austria (AT) Medical University of Łódź / Uniwersytet Medyczny w Łodzi PL Poland (PL)

How to cite

APA:

Formiga, F., Moreno-Gónzalez, R., Corsonello, A., Mattace-Raso, F., Carlsson, A.C., Ärnlöv, J.,... Chivite, D. (2024). Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease. Gerontology, 70(5), 507-516. https://doi.org/10.1159/000536465

MLA:

Formiga, Francesc, et al. "Prevalence of Sarcopenia in Chronic Heart Failure and Modulating Role of Chronic Kidney Disease." Gerontology 70.5 (2024): 507-516.

BibTeX: Download